| 
                                  Anticonvulsant effects of hesperetin in animal model of pentylenetetrazole-induced-seizures 
                                   | 
                                
								
								    S Baradaran        ,   M Ghasemi-Kasman *        ,  A Ebrahimpour        ,  SR Ahmadian        ,  M Pouramir         | 
								
								
								  | Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R.Iran , maryam.ghasemi65@gmail.com | 
								
								
								   | 
								
                                
								  | 
                                  Abstract:       (5979 Views)  | 
								
								
								  Background and objective: Hesperetin as the main flavonoid in citrus possesses various pharmacological properties including anti-oxidant and anti-inflammatory effects. In this study, the effects of hesperetin on seizures behavior and its function on total antioxidant capacity and lipid peroxidation has been investigated in pentylenetetrazol (PTZ)-induced seizures model. 
Materials and methods: In this experimental study, thirty-five mice were divided into 5 experimental groups as control, saline and hesperetin at doses of 10, 20 or 50 mg/kg. Animals received orally the related interventions for 7 days. On day 7, 30 minutes after oral gavage, convulsion was induced by single intraperitoneal (i.p.) injection of PTZ at dose of 60 mg/kg. After recording of convulsion behaviors including latency to myoclonic jerks, latency and duration of generalized tonic-clonic seizures, time to death, measuring of Ferric Reducing Antioxidant Power (FRAP) and Thiobarbituric acid reactive substances (TBARS) carried out in hippocampus tissues. 
Findings: Pretreatment with hesperetin at dose of 50 mg/kg significantly increased the latency of myoclonic jerks (hesperetin 50: P=0.0323) and generalized tonic-clonic seizures (hesperetin 10: P= 0.0003, hesperetin 20: 0.0017, hesperetin 50: P=0.0040). Hesperetin application at dose of 10 mg/kg significantly reduced the levels of TBARS compared to control group. Any significant difference in FRAP levels was not observed between different experimental groups. 
Conclusion: The results of study indicate that hesperetin might be effective as supplementary treatment in epilepsy disorder. | 
								
								
								   | 
								
								
								  | Keywords:  Hesperetin, Convulsion, Pentylenetetrazol | 
								
								
								   | 
								
								
								  | 
                                  
                                  Full-Text  [PDF 385 kb] 
                                    
                                     
                                     
                                    
									  
                                       (1484 Downloads) 
                                     
                                    
                                  | 
								
								
								  
                                  Type of Study:  Experimental |
                                  Subject: 
                                  Physiology   Received: 2018/08/5 | Accepted: 2018/10/21 | Published: 2018/10/21
                                   | 
								
                                
                                  
                                    | 
                                    
                                         | 
                                  
								
								   | 
								
								
								  | 
                                  
                                  
                                   | 
								
								
								   | 
								
								
								  | Send email to the article author | 
								
                                
                                | 
                                 |